30 Castor EDC Testimonials

Industry
Company Size
15 per page
  • 15
Reset
  • “This this a great benefit as the budget of investigator initiated studies normally won’t allow extensive monitoring of entered data.”

  • "Building the case report form was quick and easy with the FormBuilder. We highly recommend Castor."

  • "From a research manager or a coordinator’s perspective, Castor’s platform saves a lot of time, approx. 1-2 hours a day, which is a huge benefit when you’re a part of a small research team."

  • "User friendliness, affordable pricing and the flexibility of the Castor team made us choose Castor."

  • "Castor has been a wonderful partner to work with. Their solution provides us with an integrated eConsent, ePRO, and EDC that's critical in our decentralized studies. The solution is backed by a fantastic support and technical team who's always willing to work with us to find solutions."

  • "Within 1 week, our students were comfortable using Castor and able to capture data."

  • “Castor offers a truly seamless clinical trial experience for investigators and patients. Fast deployment was critical for us. Castor technology was easy to use and the self-service capability allowed us to deploy a study in just a few weeks.”

  • "What I like about Castor is that I can create a user-friendly database that will also create a user-friendly output, i.e. that I can already prepare the data as much as possible to make data analysis easier."

  • “I found it very easy to use! After watching the workshops I was able to easily create our eCRF in Castor.”

  • "Castor meets all our requirements GCP compliant, user-friendly, time-saver, audit trail."

  • "Castor strikes the right balance Comprehensive features and easy to use at an affordable price."

  • "I’m not a PC whizz, but with your guidance I was able to quickly and easily build my CRF."

  • "All things considered, it took me around 30 hours for the study build, whereas without Castor it would’ve probably taken more like 80."

  • "The rapid, widespread enrollment is a testament to the commitment of the WHO and its partners and was enabled by a design that allowed, for each patient, the rapid collection, recording, and transmission of a small amount of high-information data."

  • “We knew that if we went with Castor, we would have the support we needed moving forward, and would be able to discuss future studies and develop the tool to meet the needs of both current and future projects."